Lymphoma Research Foundation Celebrates a Legacy of Progress and a Future of Promise

Foundation Board Members, Leadership of Adolescent and Young Adult Initiative, and Teva Pharmaceuticals Honored for their Commitment to Advancing Lymphoma Research and Care

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

New York, NY (PRWEB) August 12, 2014

The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services – will host its annual Gala on October 8, 2014 at New York City’s Mandarin Oriental. Hundreds of LRF supporters will gather to celebrate not only the Foundation’s accomplishments, but to ensure that future progress is made in advancing lymphoma research.

“The Lymphoma Research Foundation’s annual Gala is an important and special event, not only for the organization but for the entire lymphoma community,” said Steven J. Prince, LRF Chairman of the Board. “A cure for lymphoma can only be realized through advanced cancer research; and LRF’s Gala is a major source of funding for lymphoma research.”

The prestigious founder’s award, the Freundlich Leadership Award, will be presented to LRF Board Members, Arlene & Robert Fischer and Phyllis & Leonard (in memoriam) Rosen for their contributions in advancing the Foundation’s mission. This year’s Distinguished Service Award will be given to the leadership of LRF’s new Adolescent and Young Adult Initiative, which includes The Paul Foundation, Founding Sponsor; Brian Levitas; and Maressa Williams. The leadership team has been instrumental in raising awareness of lymphoma and its prevalence among younger populations and addressing the unique needs of young adults with lymphoma. Teva Pharmaceuticals will receive the Corporate Leadership Award for their commitment to patient education and programming.        

“I am thrilled to recognize the significant impact that each of the Gala’s honorees have made in advancing lymphoma research and improving patient care through their partnerships with the Foundation,” said Elizabeth Thompson, LRF’s Chief Executive Officer. “The evening’s honorees are leaders and visionaries who are committed to improving the future for all those touched by lymphoma; I am confident that their continued investments in lymphoma research and care will make a meaningful difference to the more than 200 people diagnosed each day with a type of lymphoma.”

Sotheby’s C. Hugh Hildesley will serve as the Gala’s auctioneer for both the live auction, as well as for the Foundation’s signature Raise it for Research. During this unique and exciting auction last year, attendees pledged funds for lymphoma research ranging from $500 to $100,000 and raised $300,000 in minutes. The Lymphoma Research Foundation hopes for another successful Raise it for Research at this year’s Gala. Funds raised at the Gala support LRF’s mission.

For more information about the Lymphoma Research Foundation’s annual Gala or to purchase tickets to the event, please contact Taylor Zitay Kahn at (646) 465-9103 or visit lymphoma.org/gala.

About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $55 million in lymphoma-specific research. For additional information on LRF’s research, education and services, visit lymphoma.org.


Contact

Attachments